You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0405 Simultaneously forecasting burden of illness and cost-effectiveness: The case of tumour necrosis factor-alpha antagonist for ankylosing spondylitis in the dutch society

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Epidemiology, health services and outcome research
FRI0405 Simultaneously forecasting burden of illness and cost-effectiveness: The case of tumour necrosis factor-alpha antagonist for ankylosing spondylitis in the dutch society

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014300
Mar 2014700
Apr 2014200
May 2014301
Jul 2014400
Sep 2014301
Oct 2014101
Nov 2014602
Dec 2014200
Jan 2015200
Feb 2015302
Mar 2015100
Apr 2015100
Jun 2015101
Jul 2015800
Aug 2015100
Sep 2015800
Oct 2015100
Nov 2015402
Jan 2016704
Mar 2016300
Apr 2016600
May 2016600
Jun 2016300
Jul 2016200
Aug 2016400
Sep 2016400
Oct 2016200
Nov 2016200
Dec 2016200
Jan 2017300
Feb 2017400
Mar 2017800
Apr 2017300
May 20171101
Jun 2017600
Jul 2017200
Aug 20171000
Sep 2017601
Oct 2017800
Nov 2017400
Dec 2017800
Jan 2018600
Feb 2018200
Mar 2018400
Apr 2018800
May 2018800
Jul 2018400
Aug 20181401
Sep 20181000
Oct 2018800
Nov 2018600
Dec 2018401
Feb 2019200
Mar 2019600
Apr 2019200
Jun 2019200
Jul 2019200
Aug 20191200
Sep 20191000
Oct 20191600
Nov 20193002
Dec 20193001
Jan 20201100
Feb 2020100
Apr 2020200
May 2020800
Jun 2020800
Jul 2020700
Aug 2020100
Sep 20201001
Nov 20201000
Dec 2020200
Jan 2021200
Feb 2021200
Apr 2021800
May 2021200
Aug 2021100
Oct 2021400
Nov 2021201
Dec 2021400
Jan 2022200
Feb 2022400
Mar 2022200
May 2022800
Jun 2022200
Jul 20221800
Aug 2022600
Sep 2022400
Oct 2022600
Nov 2022600
Dec 2022600
Jan 20231800
Feb 20231200
Mar 2023400
May 2023200
Jun 2023200
Jul 2023400
Sep 2023600
Dec 2023800
Jan 2024200
Feb 2024200
Mar 2024400
Total574023